OTTAWA, ON , June 11, 2020 /CNW/ – The Canadian AIDS Society (CAS) is happy to announce the publication of a CAS-led protocol of Canadian medical apply tips for using plant-based hashish and cannabinoid-based merchandise within the administration of power non-cancer ache and co-occurring circumstances within the British Medical Journal (Open).
The legalization of leisure marijuana in October 2018 has highlighted the truth that the Canadian medical neighborhood has lengthy recognized a necessity for related medical tips and established finest practices for authorizing hashish and cannabinoid-based merchandise to sufferers for the remedy of power ache. As a way to treatment this information hole, CAS shaped a activity drive of leaders within the medical hashish discipline to guide within the analysis and growth of this protocol and subsequent medical apply tips. The analysis may even construct on the various different publications and research that CAS has led through the years.
We gratefully acknowledge our continued partnership with Cover Development and its medical division Spectrum Therapeutics to fund this venture and applaud their imaginative and prescient. We’d additionally wish to thank the Canadian Institute of Well being Analysis and the Arthritis Society for his or her assist.
The BMJ Open’s publication of this protocol highlights the significance of neighborhood analysis to enrich scientific analysis and that by having a holistic strategy to analysis, the affected person might be centred within the outcomes. Widespread use of this protocol and the long run tips are a big step in direction of making certain all Canadians residing with power ache throughout the nation have entry to hashish as a software for his or her ache administration.
“This analysis will pave the way in which for folks residing with power ache to have a brand new path to dealing with their ache, and due to its progressive nature, we hope that it may function a mannequin for comparable tips for different illnesses sooner or later,” says Gary Lacasse , Govt Director of CAS.
“We’re so proud to assist the unbelievable work being executed by the Canadian AIDS Society via this multi-year partnership. They’re a trailblazing, patient-centric group that has advocated for entry to medical hashish for many years,” says David Klein , CEO, Cover Development. “Our hope is that the medical tips, when revealed, will play a big function within the ongoing efforts to interrupt down boundaries to entry medical hashish in Canada and the world.”
Dr. Cecilia Costiniuk of McGill College states that “The finalization and publication of this protocol represents an necessary milestone by documenting the rationale and deliberate course of for the creation of the rules. These evidence-based tips will assist busy clinicians and sufferers make sense of the flurry of data on the market on using plant-based hashish and cannabinoid-based merchandise for the administration of power non-cancer ache and co-occurring circumstances.”
This publication is the results of the arduous work of the venture activity drive, who’re presently working to finish the complete set of tips. The duty drive is comprised of the next people:
Patrick Wright (CAS)
Gary Lacasse (CAS)
Shari Margolese (Canadian HIV Trials Community Neighborhood Advisory Board)
Dr. Zach Walsh ( College of British Columbia )
Tatiana Sanchez ( College of British Columbia )
Stephanie Arlt ( College of Victoria )
Dr. Lynne Belle-Isle (CAS)
Michelle St. Pierre ( College of British Columbia )
Dr. Alan Bell ( College of Toronto )
Dr. Paul Daeninck ( College of Manitoba )
Dr. Marilou Gagnon ( College of Victoria )
Dr. Caroline MacCallum ( College of British Columbia )
Enrico Mandarino (Neighborhood Advisory, Canadian Institutes of Well being Analysis and Canadian HIV Trials Community)
Janet Yale (Arthritis Society)
James O’Hara (Canadians for Honest Entry to Medical Marijuana)
Dr. Cecilia Costiniuk ( McGill College )